Published in J Virol on July 01, 1996
The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J Virol (1998) 2.45
Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J Virol (2002) 1.53
Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway. J Virol (2005) 1.50
Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J Virol (1998) 1.41
Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent. J Virol (2004) 1.21
Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes. Am J Pathol (2003) 1.19
Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release. J Virol (2005) 1.10
The role of B lymphocytes in coxsackievirus B3 infection. Am J Pathol (1999) 1.02
Mutational robustness of an RNA virus influences sensitivity to lethal mutagenesis. J Virol (2011) 1.01
Coxsackievirus B3 infection induces cyr61 activation via JNK to mediate cell death. J Virol (2004) 1.00
Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis. PLoS One (2012) 0.92
Coxsackievirus B3 infects the bone marrow and diminishes the restorative capacity of erythroid and lymphoid progenitors. J Virol (2012) 0.86
Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice. BMC Microbiol (2003) 0.84
Complement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centers. J Virol (1997) 0.82
Caspase-8 and FLIP regulate RIG-I/MDA5-induced innate immune host responses to picornaviruses. Future Virol (2012) 0.79
Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice. J Innate Immun (2016) 0.77
c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3. PLoS One (2014) 0.77
Coxsackievirus B3 induction of NFAT: requirement for myocarditis susceptibility. Virology (2008) 0.77
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (1993) 15.54
Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (1993) 11.15
ASPECTS OF THE PATHOGENESIS OF VIRUS DISEASES. Bacteriol Rev (1964) 5.03
Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science (1993) 4.80
Effect of virus infections on the function of the immune system. Annu Rev Microbiol (1970) 4.30
Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridization. J Clin Microbiol (1990) 3.75
Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase. Biochemistry (1991) 3.54
Viral myocarditis. A review. Am J Pathol (1980) 3.33
Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation (1992) 3.31
Organ-specific selection of viral variants during chronic infection. J Exp Med (1988) 2.71
Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis. J Virol (1990) 2.68
Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation (1990) 2.62
Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol (1994) 2.52
Germinal centres in T-cell-dependent antibody responses. Immunol Today (1992) 2.47
Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A (1992) 2.38
Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol (1995) 2.31
Antigenic competition at the level of peptide-Ia binding. Proc Natl Acad Sci U S A (1986) 2.23
Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol (1995) 2.20
Reverse transcription and direct amplification of cellular RNA transcripts by Taq polymerase. Gene (1990) 2.18
In vivo selection of lymphocyte-tropic and macrophage-tropic variants of lymphocytic choriomeningitis virus during persistent infection. J Virol (1990) 2.03
Participation of lymphocytes in viral infections. Adv Immunol (1973) 2.01
Virus-lymphocyte interaction: T cells of the helper subset are infected with lymphocytic choriomeningitis virus during persistent infection in vivo. J Virol (1987) 1.99
Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. J Med Virol (1979) 1.94
Germinal centers develop oligoclonally. Eur J Immunol (1987) 1.77
Viruses perturb lymphocyte functions: selected principles characterizing virus-induced immunosuppression. Annu Rev Immunol (1987) 1.71
Replication of poliovirus in phytohemagglutinin-stimulated human lymphocytes. J Virol (1969) 1.70
The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region. J Virol (1995) 1.64
Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab Invest (1992) 1.57
Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol (1994) 1.55
Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Am J Pathol (1995) 1.48
Virus-induced immunosuppression: a murine model of susceptibility to opportunistic infection. J Infect Dis (1988) 1.40
MULTIPLICATION OF POLIOVIRUS TYPE I IN PREPARATIONS OF HUMAN LEUKOCYTES AND ITS INHIBITION BY INTERFERON. J Immunol (1964) 1.34
Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol (1993) 1.32
Biology of germinal centers in lymphoid tissue. FASEB J (1994) 1.31
Coxsackievirus B3-induced production of tumor necrosis factor-alpha, IL-1 beta, and IL-6 in human monocytes. J Immunol (1992) 1.25
Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines. J Virol (1985) 1.24
Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation. Eur J Immunol (1992) 1.23
Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2. J Virol (1994) 1.19
Coxsackievirus-induced disease. CD4+ cells initiate both myocarditis and pancreatitis in DBA/2 mice. Am J Pathol (1989) 1.16
The central role of follicular dendritic cells in lymphoid tissues. Adv Immunol (1992) 1.13
Evidence for a macrophage-mediated effect of poliovirus on the lymphocyte response to phytohemagglutinin. J Immunol (1973) 1.09
Differential effects of myocarditic variants of Coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage. Lab Invest (1991) 1.08
Strand-specific detection of enteroviral RNA in myocardial tissue by in situ hybridization. Mol Cell Probes (1991) 1.07
Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis. J Immunol (1995) 1.05
Immunopathogenesis of experimental Coxsackievirus induced myocarditis: role of autoimmunity. Herz (1985) 0.99
Coxsackievirus B3 infection in human leukocytes and lymphoid cell lines. Blood (1994) 0.98
Impairment of immunocompetent mouse spleen cell functions by infection with coxsackievirus B3. J Infect Dis (1982) 0.94
Systemic lymphoid atrophy in coxsackievirus B3-infected mice: effects of virus and immunopotentiating agents. J Infect Dis (1985) 0.92
Virus-Containing Leukocytes in Polioencephalitis. Science (1963) 0.87
Coxsackievirus infection as a trigger of cardiac autoimmunity. Immunol Res (1989) 0.84
Replication of enteroviruses in human mononuclear cells. Isr J Med Sci (1992) 0.82
Coxsackievirus B3-positive mononuclear leukocytes in peripheral blood of Swiss and athymic mice during infection. Proc Soc Exp Biol Med (1980) 0.79
Mitochondrial origins. Proc Natl Acad Sci U S A (1985) 8.82
Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature (1996) 7.27
A phylogenetic analysis of the mycoplasmas: basis for their classification. J Bacteriol (1989) 6.66
A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med (1995) 6.14
Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recognit (2009) 3.32
The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes. Proc Natl Acad Sci U S A (2000) 3.16
T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer. Proc Natl Acad Sci U S A (2001) 3.15
A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol Cell Biol (2000) 2.70
Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis. J Virol (1990) 2.68
Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci U S A (1985) 2.67
The autopsy and the public need. Can medicine respond? Arch Pathol Lab Med (1994) 2.59
Human beta-defensins. Cell Mol Life Sci (2006) 2.57
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev (1998) 2.48
A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy. Ann Oncol (2010) 2.39
Possible association of a reduction in cardiovascular events with blood donation. Heart (1997) 2.39
Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A (1992) 2.38
Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression. Mol Cell Biol (2000) 2.35
Congenital poisoning by polychlorinated biphenyls and their contaminants in Taiwan. Science (1988) 2.35
Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol (2004) 2.34
An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med (1991) 2.27
smaug protein represses translation of unlocalized nanos mRNA in the Drosophila embryo. Genes Dev (1996) 2.22
A dedicated cone-beam CT system for musculoskeletal extremities imaging: design, optimization, and initial performance characterization. Med Phys (2011) 2.20
Repair of a specific double-strand break generated within a mammalian chromosome by yeast endonuclease I-SceI. Nucleic Acids Res (1994) 2.17
[Effect of intraocular pressure on glaucomatous damage to the optic nerve]. Ophthalmologe (2014) 2.15
Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. J Med Chem (2001) 2.06
In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci U S A (1987) 2.05
Transillumination-assisted orotracheal intubation: a comparison of the Bonfils fibrescope and the lightwand (Trachlight). Acta Anaesthesiol Scand (2012) 2.02
A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br J Cancer (2004) 2.01
TbetaR-I(6A) is a candidate tumor susceptibility allele. Cancer Res (1999) 1.99
Inhibitors of protein kinases and phosphatases alter root morphology and disorganize cortical microtubules. Plant Physiol (1997) 1.99
Morphology and microtubule organization in Arabidopsis roots exposed to oryzalin or taxol. Plant Cell Physiol (1994) 1.96
Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol (2001) 1.91
LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest (1998) 1.89
Applications of blue dextran and Cibacron Blue F3GA in purification and structural studies of nucleotide-requiring enzymes. Biochem Biophys Res Commun (1976) 1.86
Isolated pulmonic valve infective endocarditis: a diagnostically elusive entity. Am Heart J (1985) 1.86
Sinoatrial node pacemaker activity requires Ca(2+)/calmodulin-dependent protein kinase II activation. Circ Res (2000) 1.85
High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation (2005) 1.84
Mechanism of resistance of human immunodeficiency virus type 1 to 2',3'-dideoxyinosine. Proc Natl Acad Sci U S A (1993) 1.84
Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol (2000) 1.79
Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia (2004) 1.71
Brain function and macromolecules. I. Incorporation of uridine into RNA of mouse brain during short-term training experience. Proc Natl Acad Sci U S A (1966) 1.65
Clostridium ljungdahlii sp. nov., an acetogenic species in clostridial rRNA homology group I. Int J Syst Bacteriol (1993) 1.65
Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem (1994) 1.63
Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha. J Mol Cell Cardiol (2001) 1.63
A decade of acceptable autopsy rates. Does concordance of clinician and pathologist views explain relative success? Arch Pathol Lab Med (1992) 1.62
Overexpression of oskar directs ectopic activation of nanos and presumptive pole cell formation in Drosophila embryos. Cell (1992) 1.59
Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol (1987) 1.58
Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab Invest (1992) 1.57
Salmonella infection in wild birds. Br Vet J (1967) 1.56
Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J Immunol (2001) 1.55
Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. Diabetes (2001) 1.54
Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Oncogene (2001) 1.54
Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J Mol Cell Cardiol (1985) 1.52
Agenesis of the gallbladder: case report and familial investigation. Surgery (1986) 1.52
The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors. J Virol (2000) 1.50
Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol (1989) 1.50
Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res (1997) 1.50
Myosin light chain-2 luciferase transgenic mice reveal distinct regulatory programs for cardiac and skeletal muscle-specific expression of a single contractile protein gene. J Biol Chem (1992) 1.49
Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc Natl Acad Sci U S A (1992) 1.49
Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis. Br J Cancer (2012) 1.49
Global folds of proteins with low densities of NOEs using residual dipolar couplings: application to the 370-residue maltodextrin-binding protein. J Mol Biol (2000) 1.48
Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis (2003) 1.46
Immunoconjugates of geldanamycin and anti-HER2 monoclonal antibodies: antiproliferative activity on human breast carcinoma cell lines. J Natl Cancer Inst (2000) 1.46
Product release is the major contributor to kcat for the hepatitis C virus helicase-catalyzed strand separation of short duplex DNA. J Biol Chem (1998) 1.44
Orienting domains in proteins using dipolar couplings measured by liquid-state NMR: differences in solution and crystal forms of maltodextrin binding protein loaded with beta-cyclodextrin. J Mol Biol (2000) 1.43
Conducting ecologically valid prevention research: recruiting and retaining a "whole village" in multimethod, multiagent studies. Am J Community Psychol (1997) 1.43
Prevalence of abdominal aortic aneurysms in men with diabetes. Med J Aust (1997) 1.42
Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3. Mol Pharmacol (1995) 1.42
Percutaneous vasal sperm aspiration and intrauterine insemination in the treatment of obstructive azoospermia. Fertil Steril (1997) 1.41
Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J Virol (1998) 1.41
Human DNA polymerase kappa synthesizes DNA with extraordinarily low fidelity. Nucleic Acids Res (2000) 1.41
Expression of CCR6 and CD83 by cytokine-activated human neutrophils. Blood (2000) 1.40
[Isolated myocardial noncompaction in childhood-case report and review of the literature]. Z Kardiol (2003) 1.40
Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett (1994) 1.39
Complete amino acid sequence of rat brain hexokinase, deduced from the cloned cDNA, and proposed structure of a mammalian hexokinase. Proc Natl Acad Sci U S A (1989) 1.37
Brain hexokinase. A proposed relation between soluble-particulate distribution and activity in vivo. J Biol Chem (1968) 1.36
Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol (1993) 1.32
Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation (2001) 1.31
The structure of mammalian hexokinase-1. Nat Struct Biol (1998) 1.31
Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect. J Clin Invest (1995) 1.29
Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans. FASEB J (2001) 1.29
Structural determinants for the intracellular localization of the isozymes of mammalian hexokinase: intracellular localization of fusion constructs incorporating structural elements from the hexokinase isozymes and the green fluorescent protein. Arch Biochem Biophys (1997) 1.28
Initiator Met-tRNA-independent translation mediated by an internal ribosome entry site element in cricket paralysis virus-like insect viruses. Cold Spring Harb Symp Quant Biol (2001) 1.28
h-sgk serine-threonine protein kinase gene as transcriptional target of transforming growth factor beta in human intestine. Gastroenterology (1999) 1.28
Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus. Mol Cell Biochem (2001) 1.27
Intestinal cryptosporidiosis complicated by disseminated cytomegalovirus infection. Gastroenterology (1981) 1.27
Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J Virol (1995) 1.26
Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc Res (1999) 1.26
Human papillomavirus type 16-associated primary squamous cell carcinoma of the rectum. Gastroenterology (2001) 1.26
Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy. J Clin Endocrinol Metab (2000) 1.26
Crystal structure of a bovine neurophysin II dipeptide complex at 2.8 A determined from the single-wavelength anomalous scattering signal of an incorporated iodine atom. Proc Natl Acad Sci U S A (1991) 1.24
Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis. Heart (2008) 1.24
Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer. Ann Oncol (2008) 1.24
Review: modulating factors in amyloid-beta fibril formation. J Struct Biol (2000) 1.23
ATM--a key determinant of multiple cellular responses to irradiation. Acta Oncol (2001) 1.23
The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter. Oncogene (2006) 1.22
Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets. J Virol (1996) 1.22